UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001056
Receipt number R000001267
Scientific Title Study in Tohoku Preventive Effect of Camostat on Progression of Chronic Pancreatitis
Date of disclosure of the study information 2008/03/01
Last modified on 2022/11/17 17:13:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study in Tohoku Preventive Effect of Camostat on Progression of Chronic Pancreatitis

Acronym

Study in Tohoku Preventive Effect of Camostat on Progression of Chronic Pancreatitis (STOPCP)

Scientific Title

Study in Tohoku Preventive Effect of Camostat on Progression of Chronic Pancreatitis

Scientific Title:Acronym

Study in Tohoku Preventive Effect of Camostat on Progression of Chronic Pancreatitis (STOPCP)

Region

Japan


Condition

Condition

chronic pancreatitis
recurrent pancreatitis
alcoholic acute pancreatitis

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Medical treatment for chronic pancreatitis has been intended to ameliorate subjective symptom such as abdominal pain. Oral pancreatic enzymes has been used generally to treat the symptom of chronic pancreatitis. In Japan, oral proteinase inhibitor camostat mesilate (Foipan) has been also used to treat chronic pancreatitis. Here we examine the efficacy of Foipan in preventing the progression of chronic pancreatitis by an open, prospective, multicenter, randomised controlled trial.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

frequency of pancreatitis attacks

Key secondary outcomes

quality of life
glucose tolerance
pancreatic exocrine function
pancreatic fibrosis
pancreatic inflammation


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

1 tablet of Foipan to be taken three times a day (300mg/day) after meals for 21 months, following 2 tablets of Foipan three times a day (600mg/day) for 3 months.

Interventions/Control_2

1 gram of Berizym (granules) to be taken three times a day (3 gram /day) after meals for 24 months.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who recieved hospital treatment for recurrent pancreatitis or acute exacerbation of chronic pancreatitis.
Outpatients with chronic pancreatitis.
Patients with alcoholic acute pancreatitis.

Key exclusion criteria

1) Patients under 20 years old.
2) Patients with contraindications to Foipan or Berizym.
3) Patients scheduled for surgery, endoscopic treatment, or extracorporeal shock wave lithotripsy(ESWL) as treatment for pancreatitis.
4) Patients whom the attending doctor consider inappropiate to participate in this clinical study for some reason.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Tooru
Middle name
Last name Shimosegawa

Organization

Tohoku University Graduate School of Medicine

Division name

Division of Gastroenterology

Zip code

9808574

Address

1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan

TEL

022-717-7171

Email

tshimosegawa@int3.med.tohoku.ac.jp


Public contact

Name of contact person

1st name Atsushi
Middle name
Last name Masamune

Organization

Tohoku University Graduate School of Medicine

Division name

Division of Gastroenterology

Zip code

980-8574

Address

1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan

TEL

022-717-7171

Homepage URL


Email

amasamune@med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University Graduate School of Medicine
Division of Gastroenterology

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee Tohoku University Graduate School of Medicine

Address

1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan

Tel

022-717-7000

Email

med-kenkyo@bureau.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 03 Month 01 Day


Related information

URL releasing protocol

na

Publication of results

Unpublished


Result

URL related to results and publications

na

Number of participants that the trial has enrolled

100

Results

unpublished

Results date posted

2022 Year 11 Month 17 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

recurrent acute pancreatitis
chronic pancreatitis

Participant flow

follow-up for 2 years

Adverse events

none

Outcome measures

abdominal pain

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 03 Month 01 Day

Date of IRB

2008 Year 04 Month 21 Day

Anticipated trial start date

2008 Year 05 Month 01 Day

Last follow-up date

2020 Year 05 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2008 Year 02 Month 26 Day

Last modified on

2022 Year 11 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001267


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name